Articles

  • Wyeth Effexor Suit
    Aaron v. Wyeth, No. 2:07cv927 involves a patient on Effexor who eventually committed suicide. Instead of suing the doctors, the estate representative sued Wyeth, the maker of Effexor.

  • Supreme Court Rules in Wyeth v. Levine 
    The Supreme Court, by a vote of 6-3, just ruled against Wyeth v. Levine. This case turned on the concept of “pre-emption,” which says basically that federal regulations should trump state actions. Wyeth argued that because the federal government (FDA) regulates drugs, patients shouldn’t be allowed to sue in state court when drug makers follow the rules established by the FDA.
  • AstraZeneca Agrees to Bolster Seroquel Warning Label 
    "AstraZeneca Plc agreed to strengthen warnings on its antipsychotic Seroquel at the request of U.S. regulators.  The company agreed to move a statement on the risk of increased blood-sugar levels to the warnings and precautions section of Seroquel’s label.
  • Redefining death: A new ethical dilemma 
    "A days-old infant sustained severe neurological injury after being asphyxiated during birth, but the dying baby's condition did not meet the criteria for brain death -- long the only circumstance under which vital organs were procured."
  • FDA issues 'black box warning' for psoriasis drug - Raptiva 
    "The Food and Drug Administration is requiring a boxed warning to highlight the risk of life-threatening infections stemming from the use of Genentech's psoriasis drug Raptiva."

Contact Us

First Name:
Last Name:
Firm:
Address:

City:
State:
Zip:
E-mail (required):
Phone:
Fax:
Brief Summary or Question: